The ban will not prevent life insurers from using family medical history in underwriting. It will simply prohibit them from using adverse genetic tests to obtain much of the information they already have through very intrusive questions in the existing underwriting process.
The confusing public debate might be more of a risk to confidence in genetic testing
February 16, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
A good idea that will need to overcome an institutional mindset
February 19, 2025 - - Latest News -
Pharmaceuticals the latest Trump target for tariffs
February 19, 2025 - - Latest News -
IDT delivers strong first-half performance following strategic pivot
February 19, 2025 - - Latest News -
Montu announces two new appointments to leadership team
February 19, 2025 - - Latest News -
GBMA promotes prescribing shake-up to widen access and deliver savings
February 19, 2025 - - Latest News -
FDA grants fast-track designation for Neuren's NNZ-2591 in Pitt Hopkins syndrome
February 19, 2025 - - Australian Biotech -
Syntara’s topical anti-fibrotic drug leads to significant normalisation of skin in established scars
February 18, 2025 - - Australian Biotech